These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 16929495)

  • 41. [Implementation of HPV vaccination in Germany].
    Schreckenberger C; Kaufmann AM; Schneider A
    Dtsch Med Wochenschr; 2007 Oct; 132(42):2221-4. PubMed ID: 17926251
    [No Abstract]   [Full Text] [Related]  

  • 42. Assessing genital human papillomavirus genoprevalence in young Australian women following the introduction of a national vaccination program.
    Osborne SL; Tabrizi SN; Brotherton JM; Cornall AM; Wark JD; Wrede CD; Jayasinghe Y; Gertig DM; Pitts MK; Garland SM;
    Vaccine; 2015 Jan; 33(1):201-8. PubMed ID: 25444787
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Modeling the consequences of regional heterogeneity in human papillomavirus (HPV) vaccination uptake on transmission in Switzerland.
    Riesen M; Garcia V; Low N; Althaus CL
    Vaccine; 2017 Dec; 35(52):7312-7321. PubMed ID: 29126806
    [TBL] [Abstract][Full Text] [Related]  

  • 44. UK population based study to predict impact of HPV vaccination.
    Hibbitts S; Tristram A; Beer H; McRea J; Rose B; Hauke A; Nuttall D; Dallimore N; Newcombe RG; Fiander A
    J Clin Virol; 2014 Feb; 59(2):109-14. PubMed ID: 24388208
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Significant decline of HPV 6 infection and genital warts despite low HPV vaccination coverage in young women in Germany: a long-term prospective, cohort data analysis.
    Denecke A; Iftner T; Iftner A; Riedle S; Ocak M; Luyten A; Üye I; Tunc K; Petry KU
    BMC Infect Dis; 2021 Jul; 21(1):634. PubMed ID: 34215215
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Screening and vaccination: two synergic tools for the prevention of cervical cancer].
    Zaratti L; Senatore S; Franco E
    Ig Sanita Pubbl; 2007; 63(4):449-57. PubMed ID: 17912281
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The Cape Town declaration on human papillomavirus related disease.
    Williamson AL; Garland S; Palefsky J; Rybicki E; Stanley M; de Sanjosé S
    Papillomavirus Res; 2018 Jun; 5():59-60. PubMed ID: 29294358
    [No Abstract]   [Full Text] [Related]  

  • 48. Cost-effectiveness of cervical cancer prevention in Central and Eastern Europe and Central Asia.
    Berkhof J; Bogaards JA; Demirel E; Diaz M; Sharma M; Kim JJ
    Vaccine; 2013 Dec; 31 Suppl 7():H71-9. PubMed ID: 24332299
    [TBL] [Abstract][Full Text] [Related]  

  • 49. HPV genotypes: implications for worldwide cervical cancer screening and vaccination.
    Wheeler CM
    Lancet Oncol; 2010 Nov; 11(11):1013-4. PubMed ID: 20952255
    [No Abstract]   [Full Text] [Related]  

  • 50. Correspondence (letter to the editor): Vaccination is No Substitute for Early Detection?
    Weymayr C
    Dtsch Arztebl Int; 2009 Feb; 106(8):134; author reply 134. PubMed ID: 19568371
    [No Abstract]   [Full Text] [Related]  

  • 51. HPV Genotype Prevalence and Success of Vaccination to Prevent Cervical Cancer.
    Leite KRM; Pimenta R; Canavez J; Canavez F; de Souza FR; Vara L; Estivallet C; Camara-Lopes LH
    Acta Cytol; 2020; 64(5):420-424. PubMed ID: 32235115
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [HPV vaccination and testing can improve cervix cancer screening].
    Bistoletti P; Andersson S; Johansson BC
    Lakartidningen; 2008 Jan 9-15; 105(1-2):56-7. PubMed ID: 18293750
    [No Abstract]   [Full Text] [Related]  

  • 53. From India to the world--a better way to prevent cervical cancer.
    Schiffman M; Wacholder S
    N Engl J Med; 2009 Apr; 360(14):1453-5. PubMed ID: 19339726
    [No Abstract]   [Full Text] [Related]  

  • 54. Cervical high-risk human papillomavirus infection among women residing in the Gulf Cooperation Council countries: Prevalence, type-specific distribution, and correlation with cervical cytology.
    Ali MAM; Bedair RN; Abd El Atti RM
    Cancer Cytopathol; 2019 Sep; 127(9):567-577. PubMed ID: 31390155
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Application of the Cobas 4800 System for the Detection of High-Risk Human Papillomavirus in 5650 Asymptomatic Women.
    Wang S; He X; Meng F; Pan Q; Zhang L; Zeng J
    Biomed Res Int; 2020; 2020():1635324. PubMed ID: 32280677
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Human papillomavirus: science and technologies for the elimination of cervical cancer.
    Bosch FX
    Expert Opin Pharmacother; 2011 Oct; 12(14):2189-204. PubMed ID: 21756205
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Advances in cervical cancer screening and human papillomavirus vaccines.
    Feeley C
    J Br Menopause Soc; 2006 Mar; 12(1):19-23. PubMed ID: 16513018
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The Expanded Impact of Human Papillomavirus Vaccine.
    Pahud BA; Ault KA
    Infect Dis Clin North Am; 2015 Dec; 29(4):715-24. PubMed ID: 26610422
    [TBL] [Abstract][Full Text] [Related]  

  • 59. HPV testing. Visible expectations and hidden realities.
    Federschneider JM; Crum CP
    Am J Clin Pathol; 2003 Oct; 120(4):483-4. PubMed ID: 14560559
    [No Abstract]   [Full Text] [Related]  

  • 60. The Impact of the National HPV Vaccination Program in England Using the Bivalent HPV Vaccine: Surveillance of Type-Specific HPV in Young Females, 2010-2016.
    Mesher D; Panwar K; Thomas SL; Edmundson C; Choi YH; Beddows S; Soldan K
    J Infect Dis; 2018 Aug; 218(6):911-921. PubMed ID: 29917082
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.